MoneyWorks4Me

The sales for the March 2022 quarter moved up 45.20% to Rs. 24950.30 millions as compared to Rs. 17183.90 millions during the corresponding quarter last year.Net profit for the quarter ended March 2022 increased significantly by 80.96% to Rs. 8829.60 millions from Rs. 4879.30 millions.Operating profit for the quarter ended March 2022 rose to 11464.80 millions as compared to 7222.00 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 24950.30 17183.90 45.20 88798.20 67986.10 30.61 88798.20 67986.10 30.61
Other Income 505.10 228.50 121.05 1112.60 625.30 77.93 1112.60 625.30 77.93
PBIDT 11464.80 7222.00 58.75 39877.20 28832.10 38.31 39877.20 28832.10 38.31
Interest 0.40 1.80 -77.78 6.50 6.90 -5.80 6.50 6.90 -5.80
PBDT 11464.40 7220.20 58.78 39870.70 28825.20 38.32 39870.70 28825.20 38.32
Depreciation 807.50 698.40 15.62 3105.50 2546.50 21.95 3105.50 2546.50 21.95
PBT 10656.90 6521.80 63.40 36765.20 26278.70 39.90 36765.20 26278.70 39.90
TAX 1827.30 1642.50 11.25 7279.80 6731.50 8.15 7279.80 6731.50 8.15
Deferred Tax 380.40 288.50 31.85 907.80 641.00 41.62 907.80 641.00 41.62
PAT 8829.60 4879.30 80.96 29485.40 19547.20 50.84 29485.40 19547.20 50.84
Equity 530.90 530.90 0.00 530.90 530.90 0.00 530.90 530.90 0.00
PBIDTM(%) 45.95 42.03 9.33 44.91 42.41 5.89 44.91 42.41 5.89
Peers
Company Name CMP
Sun Pharma. Inds. 1759.10
Dr. Reddys Labs. 1230.50
Cipla 1313.70
Lupin 1946.00
Zydus Lifesciences 1139.00
View more..